Fritz G, Just I, Kaina B
Institute of Toxicology, Division of Applied Toxicology, University of Mainz, Germany.
Int J Cancer. 1999 May 31;81(5):682-7. doi: 10.1002/(sici)1097-0215(19990531)81:5<682::aid-ijc2>3.0.co;2-b.
Small GTPases of the Rho family are involved in the regulation of a variety of cellular processes, such as the organization of the microfilamental network, cell-cell contact and malignant transformation. To address the question of whether Rho proteins are involved in carcinogenesis in man, we compared their expression in tumors from colon, breast and lung with that of the corresponding normal tissue originating from the same patient. As shown by Rho-specific 32P-ADP-ribosylation, as well as Western-blot analysis, the amount of RhoA protein was largely increased in all 3 types of tumors tested. The most dramatic differences in the expression of Rho GTPases were observed in breast tissue. All breast tumors analyzed showed high levels of RhoA, Rac and Cdc42 proteins, whereas in the corresponding normal tissue these Rho proteins were hardly or not detectable. Progression of breast tumors from WHO grade I to grade III was accompanied by a significant average increase in RhoA protein. Overall, increase in the amount of Rho GTPases, in particular RhoA, appears to be a frequent event in different types of human tumors. This supports the view that Rho GTPases are involved in human carcinogenesis.
Rho家族的小GTP酶参与多种细胞过程的调控,如微丝网络的组织、细胞间接触和恶性转化。为了探讨Rho蛋白是否参与人类致癌过程,我们比较了结肠癌、乳腺癌和肺癌肿瘤组织与其相应的同一患者正常组织中Rho蛋白的表达。如通过Rho特异性的32P-ADP-核糖基化以及蛋白质印迹分析所示,在所有检测的3种肿瘤类型中,RhoA蛋白的量均大幅增加。在乳腺组织中观察到Rho GTP酶表达的最显著差异。所有分析的乳腺肿瘤均显示RhoA、Rac和Cdc42蛋白水平较高,而在相应的正常组织中,这些Rho蛋白几乎检测不到或无法检测到。乳腺肿瘤从世界卫生组织I级进展到III级伴随着RhoA蛋白平均显著增加。总体而言,Rho GTP酶,特别是RhoA量的增加似乎是不同类型人类肿瘤中的常见事件。这支持了Rho GTP酶参与人类致癌过程的观点。